Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China OK's ChemChina's $43 Billion Acquisition of Switzerland's Syngenta

publication date: Apr 12, 2017
China's Ministry of Commerce approved the $43 billion takeover of Switzerland's Syngenta by ChemChina, a state-owned company. The transaction is the largest acquisition of a foreign entity in any sector by a China company. Its MOFCOM approval shows that China is ready to allow large amounts of China capital to move overseas, given the right opportunity. Syngenta produces agrochemicals and seeds, and its biotech division conducts genomic research. ChemChina is a specialty chemical company with a major focus in agrochemicals. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital